SCPHARMACEUTICALS INC's ticker is SCPH and the CUSIP is 810648105. A total of 76 filers reported holding SCPHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.03 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $234,960 | -30.1% | 33,000 | 0.0% | 0.02% | -28.1% |
Q2 2023 | $336,270 | +12.3% | 33,000 | 0.0% | 0.03% | +3.2% |
Q1 2023 | $299,310 | +126191.1% | 33,000 | 0.0% | 0.03% | +14.8% |
Q4 2022 | $237 | -99.9% | 33,000 | +20.0% | 0.03% | +28.6% |
Q3 2022 | $179,000 | +148.6% | 27,500 | +83.3% | 0.02% | +162.5% |
Q2 2022 | $72,000 | -15.3% | 15,000 | 0.0% | 0.01% | 0.0% |
Q1 2022 | $85,000 | +13.3% | 15,000 | 0.0% | 0.01% | +14.3% |
Q4 2021 | $75,000 | – | 15,000 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
5AM Venture Management, LLC | 3,831,474 | $20,268,000 | 6.83% |
AIGH Capital Management LLC | 637,322 | $3,372,000 | 1.37% |
Worth Venture Partners, LLC | 162,875 | $862,000 | 0.68% |
Ikarian Capital, LLC | 1,466,147 | $7,756,000 | 0.34% |
RA Capital Management | 3,518,998 | $18,615,000 | 0.26% |
Orbimed Advisors | 4,797,148 | $25,377,000 | 0.22% |
DAFNA Capital Management LLC | 38,891 | $206,000 | 0.06% |
BOOTHBAY FUND MANAGEMENT, LLC | 150,699 | $797,000 | 0.03% |
Alyeska Investment Group, L.P. | 355,690 | $1,882,000 | 0.03% |
ALGERT GLOBAL LLC | 13,860 | $73,000 | 0.02% |